Device Ortho-Hip

Actis

Payments companies reported to CMS as associated with Actis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$20Massociated payments (2023-2025)

1,641clinicians with associated payments

5companies reporting

By year

2023 $6.7M

2024 $7.3M

2025 $5.7M

Payments reported as associated with Actis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $14M

Adult Reconstructive Orthopaedic Surgery $5.7M

Surgery $56K

Oral and Maxillofacial Surgery $9,417

Cardiovascular Disease $9,020

Orthopaedic Trauma $8,384

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Actis

These are the largest totals companies reported as associated with Actis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Robert Gorab	Orange, CA	Orthopaedic Surgery	$6,723,226.73
William Hamilton	Alexandria, VA	Adult Reconstructive Orthopaedic Surgery	$5,009,161.22
Joel Matta	Vail, CO	Orthopaedic Surgery	$4,727,085.59
Timothy Alton	Renton, WA	Orthopaedic Surgery	$548,559.58
John Redmond	Jacksonville, FL	Adult Reconstructive Orthopaedic Surgery	$375,149.96
Sayfe Jassim	Omaha, NE	Orthopaedic Surgery	$233,016.94
Robert Mayle	Stanford, CA	Orthopaedic Surgery	$163,851.54
Zachary Post	Egg Harbor Township, NJ	Orthopaedic Surgery	$120,594.11
Joseph Gondusky	Virginia Beach, VA	Orthopaedic Surgery	$103,593.90
Savyasachi Thakkar	Washington, DC	Orthopaedic Surgery	$93,436.68

Prescribed Actis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.